Similar articles

• [Prostatic cancer and pelvic node involvement: a unambiguous disease?].

  Davin JL, Culine S, Soulié M, Ravery V, Zerbib M. Davin JL, et al. Prog Urol. 2006 Apr;16(2 Suppl 1):239-56. Prog Urol. 2006. PMID: 16724684 Review. French. No abstract available.
• [The significance of pelvic lymph-node status in prostatic cancer].

  Schubert J, Heidl G, Nitzsche H, Wehnert J, Moravek P. Schubert J, et al. Z Urol Nephrol. 1983 Dec;76(12):763-70. Z Urol Nephrol. 1983. PMID: 6199912 German.
• [Staging pelvic lymphadenectomy for carcinoma of the prostate].

  Rinsho K, Ishikawa S, Nemoto R, Koiso K, Takeshima H, Uchida K. Rinsho K, et al. Hinyokika Kiyo. 1985 Sep;31(9):1583-7. Hinyokika Kiyo. 1985. PMID: 4083215 Japanese.
• Lymph node staging in potentially curable prostatic carcinoma.

  Rutishauser G, Hering F. Rutishauser G, et al. Prog Clin Biol Res. 1988;269:227-32. Prog Clin Biol Res. 1988. PMID: 3393553 No abstract available.
• Lymph node staging of potentially curable prostatic carcinoma.

  Paulson D, Okada K, Yoshida O, Rutishauser G. Paulson D, et al. Prog Clin Biol Res. 1990;357:167-84. Prog Clin Biol Res. 1990. PMID: 2217461 Review. No abstract available.